US 11291407
Detection of high risk drusen
granted A61KA61K49/0017A61P
Quick answer
US patent 11291407 (Detection of high risk drusen) held by Apellis Pharmaceuticals, Inc. expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Apellis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K49/0017, A61P, A61P27/02